Company intelligence / Profile preview

Galephar Pharmaceutical Research

Humacao, Puerto Rico, United States / Puerto Ricocmocro.com ↗

Ownership: Private
Development stage: Commercial

Overview

Galephar Pharmaceutical Research develops and manufactures oral and pulmonary drug formulations, with proprietary technologies for enhanced bioavailability and controlled release. Its products have reached commercial stage in multiple markets through licensing partners. Notable clinical results include approval of colecalciferol for vitamin D deficiency in Canada, and isotretinoin for severe acne in North/South America[2][7][10].

Therapeutic areas: GastroenterologyEndocrinologyDermatology
Modalities: Small moleculeOral drug delivery technologyPulmonary drug delivery technology
Industry: Biotech

Partnerships

Cipher PharmaceuticalsTecnofarma

Beyond the preview

Go deeper on Galephar Pharmaceutical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galephar Pharmaceutical Research.

Explore the full profile